NetworkNewsWire
Editorial Coverage: As the legalization of medical marijuana
spreads, the appetite for investment in the cannabis biotech sector
keeps growing. This is the largest sector of the legal cannabis
market, already a multi-billion-dollar market. Researchers continue
to uncover new ways that cannabinoids, chemical compounds found in
cannabis, can be used as medicine. Earth Science Tech
(ETST) (ETST
Profile) offers full-spectrum, high-grade hemp cannabidiol
(CBD) oil, and is researching cutting-edge CBD products through its
subsidiary Cannabis Therapeutics, Inc. (CTI). The creator of the
first cannabis-based prescription medicine, GW Pharma
(GWPH) is working on new drugs to tackle epilepsy, while
Medical Marijuana, Inc. (MJNA) provides a range of
CBD oils with medical and nutritional benefits to customers across
North and South America. CV Science, Inc. (CVSI)
utilizes separate drug development and consumer product divisions
to create and market a diverse range of CBD products to a variety
of markets, and Cannabis Science, Inc. (CBIS) is
developing formulation-based drugs based on cannabinoid
science.
A Thriving New Sector
The legal cannabis sector is booming. According to the
Brightfield Group, it is already worth over $7 billion and expected
to grow to $31 billion by 2021. Within that market, CBD products
are a significant sector, expected to hit
$1 billion in the next few years. Even the more conservative
U.S. states are overcoming their objections and opening up to CBD
production and sales, as legislators seek
to resolve legal ambiguities in favor of patients.
While the emergence of a recreational cannabis market in regions
such as Canada and California is exciting news for the cannabis
industry, the industry’s financial security rests on medical
products. The loosening of laws makes research easier, as does the
growing experience of medical cannabis companies. CBD is a
particularly rich source of therapeutics with the potential to be
utilized against a wide range of ailments. Researchers are
exploring its potential to tackle such enduring problems as
epilepsy, anxiety, depression and breast cancer.
Innovating in Cannabidiol
Biotechnology company Earth Science
Tech (ETST) has diverse interests within the cannabis market.
Its subsidiaries cover diagnostics and vaccines, recreational
cannabis and CBD products. In that last area, it’s leading the way
in researching and marketing a wide variety of CBD-based treatments
through innovative partnerships and collaborative research.
Earth Science Tech’s CBD work is carried out through its
subsidiary Cannabis Therapeutics, Inc. (CTI). The company’s CBD oil
is 100 percent natural and organic, catering to the environmental
concerns common among cannabis users. It is made using a CO2 liquid
extraction process that results in a full-spectrum, high-grade hemp
CBD oil that has the highest purity and quality on the market.
To keep it in the lead of the CBD market, Earth Science Tech has
created partnerships with other research bodies to produce
cutting-edge treatments. It is working with the University of
Central Oklahoma and DV Biologics Laboratory on research and
development projects to enhance the healthcare benefits of its CBD
oil. This has positioned the company to take a leadership role in
the development of cannabinoid-based pharmaceutical and
nutraceutical products. The company holds a provisional application
patent for a CBD product for treating breast and ovarian cancers,
taking CBD treatments in bold new directions.
Reaching New Market Sectors
Cannabis Therapeutics currently has two cannabinoid-based
pharmaceutical drugs and three cannabinoid-based nutraceutical
products in development. These are being made to treat a range of
ailments including anxiety, depression and fatty liver disease.
One major focus is integrating the CBD molecule with existing
generic drug molecules to create more efficient medications that
have fewer side effects than the more common approaches. The
company is therefore engaged not only in making cannabinoids useful
and available to a wider range of patients, but in creating a
better experience for existing patients.
Other research into medical cannabinoids by Earth Science Tech
could counter conservative fears about the impact of medical
cannabis on the illegal drug market. In November 2017, the company
began human trials on a new CBD formula designed to decrease
cravings and the negative effects of withdrawal in opioid addicts.
Based on industrial hemp CBD mixed with a natural ingredient that
increases dopamine levels, it could be used to counter the opioid
epidemic plaguing many countries. By turning medical CBD into a
weapon in the fight against addiction, it will reposition cannabis
in the public discourse on drug use. This has the potential to
counter resistance to the expansion of the medical cannabis
market.
Raising the Brand Profile
Earth Science Tech has a wide variety of products, giving it
good reach within the CBD market. Its CBD treatments are available
as vitamins, minerals, herbs, botanicals, personal care products,
homeopathic treatments and foods. Other products come in forms
including capsules, tablets, soft gels, chewables, liquids, creams,
sprays, powders and whole herbs. Available at retail stores across
the United States and online, they have a combination of physical
shelf presence and online visibility to raise their profile with
consumers.
The company is currently rebranding its CBD products (http://nnw.fm/s6pC1), using market research to drive
improved sales. The chief marketing officer commented, “We did a
lot of market research to see what the best angle to truly stand
out in the growing CBD industry is through our accounts,
representative feedback, and external brand analysis. I feel that
marketing, ‘High Grade Full Spectrum Cannabinoids’ will help ETST
truly stand out. Soon, the market will be able to see that ETST is
a true full spectrum CBD brand, especially with the cannabinoid
complex listing under the supplement facts.”
As a result of this research, previous marketing of the
company’s products as, “High Grade Hemp CBD Oil” is being replaced
with “High Grade Full Spectrum Cannabinoids.” Branding will also
include the addition of “Cannabinoid Complex”. The supplement facts
will show the breakdown of the full spectrum of CBD oils being
used, including CBD, CBG and CBDA.
Box packaging has been designed to incorporate these changes and
a modern, edgy look while maintaining the clean design associated
with medicinal products.
Better Distribution
Taking these revamped products into American stores (http://nnw.fm/pd51A) is the first major distributor
for Earth Science Tech’s products — Mr. Checkout.
Mr. Checkout, as featured on ABC’s Shark Tank, is a national
group of independent distributors, full-line grocery distributors
and convenience stores. It represents products in over 60 major
U.S. retail outlets with approximately 55,000 stores. Mr.
Checkout’s accounts include Walgreens, CVS, Walmart, Wholefoods
Market and Target. This distribution deal provides a direct route
for Earth Science Tech’s products onto the shelves of powerful
retail stores with a large consumer base.
Earth Science Tech has 10 active representatives opening and
managing accounts across the United States. These representatives
have been very successful with health food stores and clinics. The
distribution agreement with Mr. Checkout will take the company’s
products beyond this market, into major retailers and stores,
substantially expanding the company’s reach.
Gabriel Aviles, Earth Science Tech’s chief sales officer and
director, said about the deal, “I feel that we have finally put
together a solid productive team of representatives that we needed
to continue expanding our presence in health shops and clinics.
Now, with Mr. Checkout, we will be able to take our presence and
sales to the next level, entering larger retailers and many stores.
2018 looks to be starting off very strong with our new product
revamp, marketing and education strategy, and sales channel.”
Growing Consumer Choice
The growth of the medical cannabis sector means that Earth
Science Tech’s products sit among a wide range of brands on the
ever-growing shelves of CBD oils.
British cannabis company GW Pharma (GWPH) has
developed Sativex, the first prescription medicine derived from the
marijuana plant. This has been approved for Multiple Sclerosis
spasticity and neuropathic pain in 29 countries. The company is
currently seeking FDA
approval for Epidiolex, a CBD-based treatment for epilepsy,
after the drug was found to be effective in clinical trials.
Medical Marijuana (MJNA), one of the pioneers
of the cannabis sector in North and South America, offers its
flagship product Real Scientific Hemp Oil (RSHO) in three
varieties. RSHO was the first legal CBD oil in both Brazil and
Mexico, and the company was the first publicly traded cannabis
business in the United States. A global leader in the medical
marijuana industry, this forward-looking company is also exploring
the nutritional potential of hemp.
CV Science (CVSI) is divided into two segments:
a drug development division focused on creating and commercializing
novel CBD-based therapeutics, and a consumer product division that
manufactures, markets and sells plant-based CBD products. It is
tapping into a wide range of market sectors through products such
as its Purified Liquids products for vaping. Its PlusCBD Oil is the
top-selling brand of hemp-derived CBD oil for consumers in the
natural products industry.
Recognizing the long history of cannabinoids for health purposes
and supporting peer-reviewed scientific journals, Cannabis
Science (CBIS) is focused on the discovery and development
of novel cannabinoid-based therapies as treatment options for unmet
medical needs. Its immediate focus is on the treatment of
cancer.
Cannabinoids are an increasingly important part of the growing
cannabis sector. Companies that can combine strong branding,
customer outreach and innovative products are likely to see great
growth as the market expands by billions each year. And as research
finds new therapeutic uses for these chemicals, they are set to
improve the lives of thousands of patients.
For more information on Earth Science Tech, visit Earth Science
Tech (ETST)
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content
distribution company that provides (1) access to a network of wire
services via NetworkWire to
reach all target markets, industries and demographics in the most
effective manner possible, (2) article and editorial syndication to
5,000+ news outlets (3), enhanced press release services to ensure
maximum impact, (4) social media distribution via the Investor
Brand Network (IBN) to nearly 2 million followers, (5) a full array
of corporate communications solutions, and (6) a total news
coverage solution with NNW Prime. As a
multifaceted organization with an extensive team of contributing
journalists and writers, NNW is uniquely positioned to best serve
private and public companies that desire to reach a wide audience
of investors, consumers, journalists and the general public. By
cutting through the overload of information in today’s market, NNW
brings its clients unparalleled visibility, recognition and brand
awareness. NNW is where news, content and information converge.
For more information, please visit https://www.NetworkNewsWire.com
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Please see full terms of use and disclaimers on the
NetworkNewsWire website applicable to all content provided by NNW,
wherever published or re-published: http://NNW.fm/Disclaimer
DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article
and content set forth above. References to any issuer other than
the profiled issuer are intended solely to identify industry
participants and do not constitute an endorsement of any issuer and
do not constitute a comparison to the profiled issuer. The
commentary, views and opinions expressed in this release by NNW are
solely those of NNW. Readers of this Article and content agree that
they cannot and will not seek to hold liable NNW for any investment
decisions by their readers or subscribers. NNW is a news
dissemination and financial marketing solutions provider and are
NOT registered broker-dealers/analysts/investment advisers, hold no
investment licenses and may NOT sell, offer to sell or offer to buy
any security.
The Article and content related to the profiled company
represent the personal and subjective views of the Author, and are
subject to change at any time without notice. The information
provided in the Article and the content has been obtained from
sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all
such information. None of the Author, NNW, or any of their
respective affiliates, guarantee the accuracy or completeness of
any such information. This Article and content are not, and should
not be regarded as investment advice or as a recommendation
regarding any particular security or course of action; readers are
strongly urged to speak with their own investment advisor and
review all of the profiled issuer’s filings made with the
Securities and Exchange Commission before making any investment
decisions and should understand the risks associated with an
investment in the profiled issuer’s securities, including, but not
limited to, the complete loss of your investment.
NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. “Forward-looking statements” describe future expectations,
plans, results, or strategies and are generally preceded by words
such as “may”, “future”, “plan” or “planned”, “will” or “should”,
“expected,” “anticipates”, “draft”, “eventually” or “projected”.
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company’s annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and NNW undertakes no
obligation to update such statements.
Source:
NetworkNewsWire
Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Earth Science Tech (PK) (USOTC:ETST)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
Earth Science Tech (PK) (USOTC:ETST)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024
